BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15217486)

  • 21. 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.
    Jansson AK; Gunnarsson C; Cohen M; Sivik T; Stål O
    Cancer Res; 2006 Dec; 66(23):11471-7. PubMed ID: 17145895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A putative role for psoriasin in breast tumor progression.
    Krop I; März A; Carlsson H; Li X; Bloushtain-Qimron N; Hu M; Gelman R; Sabel MS; Schnitt S; Ramaswamy S; Kleer CG; Enerbäck C; Polyak K
    Cancer Res; 2005 Dec; 65(24):11326-34. PubMed ID: 16357139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
    Nagai MA; Fregnani JH; Netto MM; Brentani MM; Soares FA
    Breast Cancer Res Treat; 2007 Nov; 106(1):49-56. PubMed ID: 17211533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S100-annexin complexes--biology of conditional association.
    Miwa N; Uebi T; Kawamura S
    FEBS J; 2008 Oct; 275(20):4945-55. PubMed ID: 18795952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of binding sites on S100A7, a participant in cancer and inflammation pathways.
    León R; Murray JI; Cragg G; Farnell B; West NR; Pace TC; Watson PH; Bohne C; Boulanger MJ; Hof F
    Biochemistry; 2009 Nov; 48(44):10591-600. PubMed ID: 19810752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of genes with altered expression in medullary breast cancer vs. ductal breast cancer and normal breast epithelia.
    Gjerstorff MF; Benoit VM; Laenkholm AV; Nielsen O; Johansen LE; Ditzel HJ
    Int J Oncol; 2006 Jun; 28(6):1327-35. PubMed ID: 16685433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
    Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I
    Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional regulation of the insulin-like growth factor-I receptor gene in breast cancer.
    Sarfstein R; Maor S; Reizner N; Abramovitch S; Werner H
    Mol Cell Endocrinol; 2006 Jun; 252(1-2):241-6. PubMed ID: 16647191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
    Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
    Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
    Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
    Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and validation of S100A7 associated with lung squamous cell carcinoma metastasis to brain.
    Zhang H; Wang Y; Chen Y; Sun S; Li N; Lv D; Liu C; Huang L; He D; Xiao X
    Lung Cancer; 2007 Jul; 57(1):37-45. PubMed ID: 17418446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S100 proteins and their influence on pro-survival pathways in cancer.
    Emberley ED; Murphy LC; Watson PH
    Biochem Cell Biol; 2004 Aug; 82(4):508-15. PubMed ID: 15284904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico analysis and verification of S100 gene expression in gastric cancer.
    Liu J; Li X; Dong GL; Zhang HW; Chen DL; Du JJ; Zheng JY; Li JP; Wang WZ
    BMC Cancer; 2008 Sep; 8():261. PubMed ID: 18793447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis.
    Webb M; Emberley ED; Lizardo M; Alowami S; Qing G; Alfia'ar A; Snell-Curtis LJ; Niu Y; Civetta A; Myal Y; Shiu R; Murphy LC; Watson PH
    BMC Cancer; 2005 Feb; 5():17. PubMed ID: 15717926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22.
    Moog-Lutz C; Bouillet P; Régnier CH; Tomasetto C; Mattei MG; Chenard MP; Anglard P; Rio MC; Basset P
    Int J Cancer; 1995 Oct; 63(2):297-303. PubMed ID: 7591220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S100A3 mRNA expression displays an inverse correlation to breast cancer progression.
    Lloyd BH; Ruddell C; Rudland PS; Barraclough R
    Biochem Soc Trans; 1996 Aug; 24(3):340S. PubMed ID: 8878884
    [No Abstract]   [Full Text] [Related]  

  • 39. S100A7 (Psoriasin)--mechanism of antibacterial action in wounds.
    Lee KC; Eckert RL
    J Invest Dermatol; 2007 Apr; 127(4):945-57. PubMed ID: 17159909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The S100 proteins for screening and prognostic grading of bladder cancer.
    Yao R; Davidson DD; Lopez-Beltran A; MacLennan GT; Montironi R; Cheng L
    Histol Histopathol; 2007 Sep; 22(9):1025-32. PubMed ID: 17523080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.